Every open market buy and sale of Health Catalyst, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $105K bought and $342K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when HCAT insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an HCAT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every HCAT insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Benjamin LandryGeneral Counsel | Sale plan | 99,478 | $1.42 | $141K | 251,894 | Nov 13Form 4 |
| Sep 14, 2026 | Simeon KohlCEO | Buy | 59,000 | $1.79 | $105K | 2,856,385 | Sep 16Form 4 |
| Dec 5, 2025 | Benjamin LandryGeneral Counsel | Sale plan | 27,425 | $2.64 | $72K | 100,000 | Dec 9Form 4 |
| Dec 4, 2025 | Julie Larson-GreenDirector | Sale | 47,997 | $2.67 | $128K | 73,573 | Dec 9Form 4 |
| Sep 5, 2025 | Benjamin LandryGeneral Counsel | Sale plan | 6,175 | $3.35 | $21K | 141,812 | Sep 9Form 4 |
| Jun 5, 2025 | Benjamin LandryGeneral Counsel | Sale plan | 6,057 | $3.94 | $24K | 151,125 | Jun 9Form 4 |
| May 5, 2025 | Daniel LeSueurCOO | Sale plan | 5,209 | $4.10 | $21K | 205,832 | May 7Form 4 |
| Apr 3, 2025 | Daniel LeSueurCOO | Sale plan | 5,209 | $4.15 | $22K | 211,041 | Apr 7Form 4 |
| Mar 6, 2025 | Benjamin LandryGeneral Counsel | Sale plan | 13,827 | $4.55 | $63K | 160,437 | Mar 10Form 4 |
| Mar 5, 2025 | Daniel LeSueurCOO | Sale plan | 16,902 | $4.52 | $76K | 216,250 | Mar 10Form 4 |
| Feb 18, 2025 | Linda LlewelynChief People Officer | Sale plan | 6,441 | $5.43 | $35K | 85,819 | Feb 20Form 4 |
| Feb 5, 2025 | Daniel LeSueurCOO | Sale plan | 5,209 | $5.76 | $30K | 86,044 | Feb 6Form 4 |
| Jan 15, 2025 | Linda LlewelynChief People Officer | Sale plan | 6,442 | $5.80 | $37K | 92,260 | Jan 17Form 4 |
| Jan 6, 2025 | Benjamin LandryGeneral Counsel | Sale plan | 2,500 | $7.52 | $19K | 72,250 | Jan 10Form 4 |
| Jan 6, 2025 | Daniel LeSueurCOO | Sale plan | 5,209 | $7.51 | $39K | 91,253 | Jan 10Form 4 |
HCAT insider trading FAQ
Are HCAT insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $105K of HCAT on the open market in 1 trades, and 2 sold $342K in 3 trades, 62% of that under pre-arranged trading plans.
When did an HCAT insider last buy shares?
Simeon Kohl (CEO) bought 59,000 shares for $105K on Sep 14, 2026, reported on Sep 16, 2026.
When did an HCAT insider last sell shares?
Benjamin Landry (General Counsel) sold 99,478 shares for $141K on Nov 12, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
